| Primary |
| Pleural Effusion |
20.0% |
| Tuberculosis |
20.0% |
| Atypical Mycobacterial Infection |
17.5% |
| Tuberculous Pleurisy |
12.5% |
| Tuberculosis Of Central Nervous System |
10.0% |
| Disseminated Tuberculosis |
5.0% |
| Mycobacterium Avium Complex Infection |
5.0% |
| Alanine Aminotransferase Abnormal |
2.5% |
| Arthritis |
2.5% |
| Drug Therapy |
2.5% |
| Mycobacterial Infection |
2.5% |
|
| Hepatitis Fulminant |
13.3% |
| Thrombocytopenia |
13.3% |
| Visual Field Defect |
13.3% |
| Blindness |
6.7% |
| Hyperuricaemia |
6.7% |
| Nausea |
6.7% |
| Paraesthesia |
6.7% |
| Sputum Culture Positive |
6.7% |
| Tuberculosis |
6.7% |
| Visual Acuity Reduced |
6.7% |
| Visual Impairment |
6.7% |
| Vomiting |
6.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
30.8% |
| Hiv Infection |
19.9% |
| Pulmonary Tuberculosis |
12.8% |
| Mycobacterium Avium Complex Infection |
8.0% |
| Tuberculosis |
7.6% |
| Cytomegalovirus Infection |
3.4% |
| Disseminated Tuberculosis |
3.0% |
| Prophylaxis |
2.5% |
| Aortic Valve Replacement |
2.0% |
| General Symptom |
1.6% |
| Hypersensitivity |
1.6% |
| Hypertension |
1.4% |
| Angioplasty |
0.8% |
| Antibiotic Prophylaxis |
0.8% |
| Antifungal Prophylaxis |
0.8% |
| Acquired Immunodeficiency Syndrome |
0.7% |
| Systemic Lupus Erythematosus |
0.7% |
| Acute Myocardial Infarction |
0.6% |
| Atypical Mycobacterial Infection |
0.6% |
| Diabetes Mellitus |
0.6% |
|
| Vomiting |
23.0% |
| Pneumonia Aspiration |
8.1% |
| Drug Ineffective |
5.4% |
| Hypertensive Encephalopathy |
5.4% |
| Hyponatraemia |
5.4% |
| Liver Disorder |
5.4% |
| Thrombosis In Device |
5.4% |
| Ventricular Septal Defect |
5.4% |
| Hepatotoxicity |
4.1% |
| Pain In Extremity |
4.1% |
| Weight Decreased |
4.1% |
| Autoimmune Hepatitis |
2.7% |
| Death |
2.7% |
| Hepatic Enzyme Increased |
2.7% |
| Hepatic Failure |
2.7% |
| Optic Neuritis |
2.7% |
| Oral Mucosa Erosion |
2.7% |
| Pregnancy |
2.7% |
| Renal Failure Acute |
2.7% |
| Renal Tubular Necrosis |
2.7% |
|
| Concomitant |
| Hiv Infection |
29.2% |
| Tuberculosis |
13.4% |
| Pulmonary Tuberculosis |
13.1% |
| Drug Use For Unknown Indication |
8.3% |
| Mycobacterium Avium Complex Infection |
7.6% |
| Mycobacterial Infection |
3.7% |
| Acquired Immunodeficiency Syndrome |
3.0% |
| Prophylaxis |
2.7% |
| Lymph Node Tuberculosis |
2.5% |
| Rheumatoid Arthritis |
2.2% |
| Hypertension |
1.9% |
| Meningitis Tuberculous |
1.8% |
| Atypical Mycobacterial Infection |
1.7% |
| Prophylaxis Against Transplant Rejection |
1.4% |
| Disseminated Tuberculosis |
1.3% |
| Ill-defined Disorder |
1.3% |
| Mycobacteria Test |
1.3% |
| Cerebral Toxoplasmosis |
1.2% |
| Pneumonia |
1.2% |
| Antibiotic Prophylaxis |
1.1% |
|
| Psychotic Disorder |
8.9% |
| White Blood Cell Count Decreased |
8.0% |
| Epilepsy |
6.3% |
| Immune Reconstitution Syndrome |
6.3% |
| Platelet Count Decreased |
6.3% |
| Pyrexia |
6.3% |
| Renal Failure Acute |
6.3% |
| Weight Decreased |
6.3% |
| Rash |
5.4% |
| Confusional State |
4.5% |
| Pancreatitis Acute |
4.5% |
| Sepsis |
4.5% |
| Tuberculosis |
4.5% |
| Vomiting |
4.5% |
| Convulsion |
3.6% |
| Pruritus |
3.6% |
| Hypertensive Encephalopathy |
2.7% |
| Memory Impairment |
2.7% |
| Pancytopenia |
2.7% |
| Peritoneal Tuberculosis |
2.7% |
|
| Interacting |
| Tuberculosis |
31.0% |
| Acute Myocardial Infarction |
10.3% |
| Angioplasty |
10.3% |
| Mycobacterium Avium Complex Infection |
10.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
10.3% |
| Renal Cell Carcinoma Stage Iv |
10.3% |
| Stent Placement |
10.3% |
| Renal Transplant |
6.9% |
|
| Tuberculosis |
60.0% |
| Thrombosis In Device |
20.0% |
| Weight Decreased |
20.0% |
|
